For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221230:nRSd2594La&default-theme=true
RNS Number : 2594L Life Settlement Assets PLC 30 December 2022
Life Settlement Assets PLC (the "Company" or "LSA")
LEI: 2138003OL2VBXWG1BZ27
Further update re sale of Mutual Benefits Keep Policy Trust ("MBC")
Further to the Company's announcement of the 12 December, LSA today notes the
formal filing on 28 December 2022 with the US Court of the Southern District
of Florida, Miami Division (the "Court") by MBC of its motion to the Court to
approve the sale of a portfolio of life policies (the "Portfolio") to Acheron
Portfolio Trust ("APT") (on behalf of LSA) for a gross consideration of $24
million (subject to adjustment for changes in the Portfolio such as
maturities). The motion, which includes a settlement agreement with APT, is
expected to be heard by the Court on 26 January 2023. If approved by the
Court the proceeds of the sale, net of all transaction, legal and wind down
costs which are not expected to exceed $5 million, will be distributed to
MBC's investors, including APT (as a current investor). As at 1 December
2022 the face value attributed to the Portfolio was US$167 million, of which
approximately 63% is attributable to APT's interests.
LSA expects to be able to comment further after the court hearing.
30 December 2022
For further information contact
Acheron Capital Limited (Investment Manager)
Jean-Michel Paul
020 7258 5990
Shore Capital (Financial Adviser and Broker)
Robert Finlay
020 7408 4090
ISCA Administration Services Limited
Company Secretary
Tel: 01392 487056
Notes to Editors
Life Settlement Assets PLC is a closed-ended investment trust company which
invests in, and manages, portfolios of whole and fractional interests in life
settlement policies issued by life insurance companies operating predominantly
in the United States. The Company seeks to generate long-term returns for
investors by investing in the life settlement market, through each of the
separate Share Classes. The Company aims to manage its investment in
portfolios of life settlement products so that the realised value of the
policy maturities exceeds the aggregate cost of acquiring the policies,
ongoing premiums, management fees and other operational costs.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END STRBCBDDISDDGDC